These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22363786)

  • 1. Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1.
    Jansson L; Larsson J
    PLoS One; 2012; 7(2):e32013. PubMed ID: 22363786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo Signaling Pathway Regulates Ovarian Function via the Proliferation of Ovarian Germline Stem Cells.
    Ye H; Li X; Zheng T; Hu C; Pan Z; Huang J; Li J; Li W; Zheng Y
    Cell Physiol Biochem; 2017; 41(3):1051-1062. PubMed ID: 28245464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice.
    Hu LL; Su T; Luo RC; Zheng YH; Huang J; Zhong ZS; Nie J; Zheng LP
    J Cell Physiol; 2019 Feb; 234(2):1578-1587. PubMed ID: 30078193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YAP1 increases organ size and expands undifferentiated progenitor cells.
    Camargo FD; Gokhale S; Johnnidis JB; Fu D; Bell GW; Jaenisch R; Brummelkamp TR
    Curr Biol; 2007 Dec; 17(23):2054-60. PubMed ID: 17980593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
    Ota M; Sasaki H
    Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
    Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
    Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
    Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
    Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
    Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
    Cancer Lett; 2018 Jun; 423():36-46. PubMed ID: 29452146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
    Nagashima S; Bao Y; Hata Y
    Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1.
    Li Y; Hibbs MA; Gard AL; Shylo NA; Yun K
    Stem Cells; 2012 Apr; 30(4):741-52. PubMed ID: 22232070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
    Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
    Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDR functions as a physiological YAP1 kinase in the intestinal epithelium.
    Zhang L; Tang F; Terracciano L; Hynx D; Kohler R; Bichet S; Hess D; Cron P; Hemmings BA; Hergovich A; Schmitz-Rohmer D
    Curr Biol; 2015 Feb; 25(3):296-305. PubMed ID: 25601544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.
    Bora-Singhal N; Nguyen J; Schaal C; Perumal D; Singh S; Coppola D; Chellappan S
    Stem Cells; 2015 Jun; 33(6):1705-18. PubMed ID: 25754111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.